Use of Normal Tissue Complication Probability Models in the Clinic

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 3 SUPPL., 2010, Pages

  Marks, Lawrence B ^a   Yorke, Ellen D ^b   Jackson, Andrew ^b   Ten Haken, Randall K ^c   Constine, Louis S ^d   Eisbruch, Avraham ^c   Bentzen, Søren M ^e   Nam, Jiho ^a   Deasy, Joseph O ^f  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^e UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^f USA   (United States)

Author keywords

NTCP; QUANTEC

Indexed keywords

NORMAL TISSUE; NORMAL-TISSUE COMPLICATION PROBABILITY MODELS; QUANTITATIVE ANALYSIS;

THREE DIMENSIONAL;

ARTICLE; DOSIMETRY; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; ORGAN SIZE; OUTPATIENT DEPARTMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION INJURY; TREATMENT OUTCOME;

ADULT; CHILD; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MODELS, BIOLOGICAL; MODELS, STATISTICAL; ORGAN SPECIFICITY; PRACTICE GUIDELINES AS TOPIC; RADIATION INJURIES; RADIATION ONCOLOGY; RADIATION TOLERANCE;

EID: 76449106780     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.07.1754     Document Type: Article

References (29)

1. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 109-122
2. Kirkpatrick J., Meyer J., and Marks L. The linear-quadratic model is inappropriate to model high-dose per fraction effects. Semin Radiat Oncol 18 (2008) 240-243
3. Trotti A., Colevas A.D., Setser A., et al. CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13 (2003) 176-181
4. Langer M., Morrill S.S., and Lane R. A test of the claim that plan rankings are determined by relative complication and tumor-control probabilities. Int J Radiat Oncol Biol Phys 41 (1998) 451-457
5. Agren A., Brahme A., and Turesson I. Optimization of uncomplicated control for head and neck tumors. Int J Radiat Oncol Biol Phys 19 (1990) 1077-1085
6. Miften M.G.O., Parda D.S., Prosnitz R.G., and Marks L.M. Using quality of life information to rationally incorporate normal tissue effects into treatment plan evaluation and scoring. In: Rubin P.C.L., Marks L.B., and Okunieff P. (Eds). Cured I-lent. Late effects of cancer treatment on normal tissue. 1st ed (2007), Springer, New York
7. Amols H.I., Zaider M., Hayes M.K., et al. Physician/patient-driven risk assignment in radiation oncology: Reality or fancy?. Int J Radiat Oncol Biol Phys 38 (1997) 455-461
8. Morris D.E. Clinical experience with retreatment for palliation. Semin Radiat Oncol 10 (2000) 210-221
9. Sadikov E., Bezjak A., Yi Q.L., et al. Value of whole brain re-irradiation for brain metastases-single centre experience. Clin Oncol 19 (2007) 532-538
10. Kurup P., Reddy S., and Hendrickson F.R. Results of re-irradiation for cerebral metastases. Cancer 46 (1980) 2587-2589
11. Pfeffer M.R., Rabin T., Tsvang L., et al. Orbital lymphoma: Is it necessary to treat the entire orbit?. Int J Radiat Oncol Biol Phys 60 (2004) 527-530
12. Hope A.J., Lindsay P.E., El Naqa I., et al. Clinical, dosimetric, and location-related factors to predict local control in non-small cell lung cancer. Int J Radiat Oncol Biol Phys 63 (2005) S231-S231
13. Engels B., Soete G., Verellen D., et al. Conformal Arc Radiotherapy for Prostate Cancer: Increased Biochemical Failure in Patients With Distended Rectum on the Planning Computed Tomogram Despite Image Guidance by Implanted Markers. Int J Radiat Oncol Biol Phys 74 (2009) 388-391
14. Zagars G.K., Schultheiss T.E., and Peters L.J. Inter-tumor heterogeneity and radiation dose-control curves. Radiother Oncol 8 (1987) 353-361
15. Jolles B. Area factor in skin reaction. Br Emp Cancer Campaign Rep (1939) 16
16. Lyman J.T. Complication probability as assessed from dose-volume histograms. Radiat Res Suppl 8 (1985) S13-S19
17. Mohan R., Mageras G.S., Baldwin B., et al. Clinically relevant optimization of 3-D conformal treatments. AAPM 19 (1992) 933-944
18. Niemierko A. A generalized concept of equivalent uniform dose (EUD). Med Phys 26 (1999) 1100
19. Kutcher G.J., Burman C., Brewster L., et al. Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations. Int J Radiat Oncol Biol Phys 21 (1991) 137-146
20. Burman C., Kutcher G.J., Emami B., et al. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 21 (1991) 123-135
21. Withers H.R., Tayor J.M.G., and Maciejewski B. Treatment volume and tissue tolerance. Int J Radiat Oncol Biol Phys 15 (1988) 751-759
22. Jackson A., Ten Haken R.K., Robertson J.M., et al. Analysis of clinical complication data for radiation hepatitis using a parallel architecture model. Int J Radiat Oncol Biol Phys 31 (1995) 883-891
23. Niemierko A., and Goitein M. Calculation of normal tissue complication probability and dose-volume histogram reduction schemes for tissues with a critical element architecture. Radiother Oncol 20 (1991) 166-176
24. Graham M.V., Purdy J.A., Emami B., et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 45 (1999) 323-329
25. El Naqa I., Bradley J., Blanco A.I., et al. Multivariable modeling of radiotherapy outcomes including dose-volume and clinical factors. Int J Radiat Oncol Biol Phys 64 (2006) 1275-1286
26. Jackson A., and Yorke E. NTCP and TCP for treatment planning. In: Memorial Sloan-Kettering Cancer Center (Ed). A practical guide to intensity-modulated radiation therapy (2003), Medical Physics Pubishers, Madison, WI 185-220
27. Deasy J.O., Niemierko A., Herbert D., et al. Methodological issues in radiation dose-volume outcome analyses: Summary of a joint AAPM/NIH workshop. Med Phys 29 (2002) 2109-2127
28. Yorke E.D. Modeling the effects of inhomogeneous dose distributions in normal tissues. Semin Radiat Oncol 11 (2001) 197-209
29. Moiseenko J., Deasy O., and Van Dyk J. Radiobiological modeling for treatment planning. In: Van Dyk J. (Ed). The modern technology of radiation oncology: A compendium for medical physicists and radiation oncologists, vol. 2 (2005), Medical Physics Publishing, Madison, WI 185-220